Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Lyell Immunopharma (LYEL) Other Gross PP&E Adjustments (2020 - 2025)

Lyell Immunopharma (LYEL) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with $82.3 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 2.16% to $82.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $82.3 million through Dec 2025, down 2.16% year-over-year, with the annual reading at $82.3 million for FY2025, 2.16% down from the prior year.
  • Other Gross PP&E Adjustments hit $82.3 million in Q4 2025 for Lyell Immunopharma, up from -$19.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $104.7 million in Q4 2022 to a low of -$48.4 million in Q2 2021.
  • Historically, Other Gross PP&E Adjustments has averaged -$3.8 million across 5 years, with a median of -$37.7 million in 2024.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 184.33% in 2021 and later fell 18.66% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $85.2 million in 2021, then rose by 22.88% to $104.7 million in 2022, then dropped by 1.24% to $103.4 million in 2023, then dropped by 18.66% to $84.1 million in 2024, then fell by 2.16% to $82.3 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for LYEL at $82.3 million in Q4 2025, -$19.9 million in Q3 2025, and -$21.0 million in Q2 2025.